A chemical upcycling process that simultaneously performs acid hydrolysis and polysaccharide grafting on mixed polyester packaging waste to produce antibacterial copolymer films with enhanced thermal stability, barrier properties, and mechanical performance while preserving biodegradability.
This research proposes a novel chemical upcycling method for mixed polyester packaging waste, including PLA and PHAs, that combines simultaneous acid hydrolysis with polysaccharide grafting to produce high-performance copolymer films. The process targets FDA-compliant polysaccharides such as chitosan and cellulose acetate, leveraging amidation or transesterification reactions with exposed polyester end groups. A key advantage is the ability to process mixed-material packaging directly, without the need for preliminary isolation or separation of individual polymer components, simplifying recycling workflows and reducing costs. The resulting films exhibit antibacterial properties, improved barrier performance, and enhanced mechanical characteristics while retaining biodegradability. By improving thermal stability, the approach enables multiple thermal processing cycles before end-of-life biodegradation, addressing a critical limitation that has hindered broader adoption of biodegradable polyesters in commodity packaging.
Key features:
Planned characterization methods:
This technology is at an early-to-mid stage of development. Simultaneous acid hydrolysis and grafting of aliphatic polyesters with polysaccharides has been demonstrated in prior literature but remains time-intensive with poorly understood final copolymer properties. The proposed research aims to advance the technology through three phases: developing scalable acid hydrolysis-grafting pathways using green solvents and catalysts, comprehensively characterizing how polyester chain length and polysaccharide content affect film performance, and demonstrating scalability through pilot-scale reactor design with energy footprint and cost analysis. The work is currently in the research planning and validation phase, with future steps including pilot-scale demonstration and preliminary techno-economic analysis.
Northwestern University is a comprehensive private research university with campuses in Evanston and downtown Chicago and a collaborative, cross‑disciplinary culture. Integration with a major hospital system enables clinical research, diverse patient access, and rapid translation from bench to bedside. Shared research cores, prototyping facilities, a campus incubator, and dedicated corporate engagement teams make it straightforward to scope projects, structure agreements, and place talent. Research is supported by competitive federal funding from agencies such as NIH, NSF, DOE, and DoD, complemented by foundation and industry partnerships. A dedicated technology transfer office advances IP strategy, licensing, and startup formation.